Introduction to the Special Issue on "The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update"

Melanie Y. Bertram * , Tessa Tan Torres Edejer

Cited by CrossRef:

1- Fitzpatrick M, Laufer R, Baral R, Driscoll A, Feikin D, Fleming J, Jit M, Kim S, Koltai M, Li Y, Li X, Nair H, Neuzil K, Pecenka C, Sparrow E, Srikantiah P, Ortiz J. Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022. Vaccine. 2023;41(48):7047 [Crossref]

2- Sen S, Braunack-Mayer L, Kelly S, Masserey T, Malinga J, Moehrle J, Penny M. Public health impact of current and proposed age-expanded perennial malaria chemoprevention: a modelling study. Sci Rep. 2025;15(1) [Crossref]

3- Marx M, Mounié M, Mosnier I, Venail F, Mondain M, Uziel A, Bakhos D, Lescanne E, N’Guyen Y, Bernardeschi D, Sterkers O, Godey B, Creff G, Schmerber S, Bonne N, Vincent C, Fraysse B, Deguine O, Costa N. Cost-utility of cochlear implantation in single-sided deafness and asymmetric hearing loss: results of a randomized controlled trial. Eur J Health Econ. 2024; [Crossref]

4- Charlton V. The ethics of aggregation in cost-effectiveness analysis or, “on books, bookshelves, and budget impact”. FrontHealth Serv. 2022;2 [Crossref]

5- Wang H, Wang Y, Li L, Zhou H, Lili S, Li L, Yike S, Aixia M. Economic evaluation of first-line nivolumab plus cabozantinib for advanced renal cell carcinoma in China. Front Public Health. 2022;10 [Crossref]

6- Moradzadeh M, Karamouzian M, Najafizadeh S, Yazdi-Feyzabadi V, Haghdoost A. International Journal of Health Policy and Management (IJHPM): A Decade of Advancing Knowledge and Influencing Global Health Policy (2013-2023). Int J Health Policy Manag. 2023;12:8124 [Crossref]

7- Mfutso-Bengo J, Jeremiah F, Kasende-Chinguwo F, Ng’ambi W, Nkungula N, Kazanga-Chiumia I, Juma M, Chawani M, Chinkhumba J, Twea P, Chirwa E, Langwe K, Manthalu G, Ngwira L, Nkhoma D, Colbourn T, Revill P, Sculpher M. A qualitative study on the feasibility and acceptability of institutionalizing health technology assessment in Malawi. BMC Health Serv Res. 2023;23(1) [Crossref]

8- Trajman A, Adjobimey M, Bastos M, Valiquette C, Oxlade O, Fregonese F, Affolabi D, Cordeiro-Santos M, Stein R, Benedetti A, Menzies D. GeneXpert or chest-X-ray or tuberculin skin testing for household contact assessment (GXT): protocol for a cluster-randomized trial. Trials. 2022;23(1) [Crossref]

Submit Your Paper Archive